Oncogene-induced replication stress is recognized as the primary cause of accumulation of DNA damage and genome instability in precancerous cells. Although the molecular mechanisms responding to such type of replication perturbation are not fully characterized, it has been speculated that their dysfunction may enhance genome instability and accelerate tumor progression. Here, we show that the WRN protein, a member of the human RecQ helicases, is necessary to sustain replication fork progression in response to oncogene-induced replication stress. Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress. Moreover, we demonstrate that double-strand breaks, observed upon oncogene over-expression, depend on the MUS81 endonuclease, which represents a parallel pathway collaborating with WRN to prevent cell death. Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factor\s that, when mutated or dysfunctional, may enhance genome instability in precancerous cells. In addition, because concomitant depletion of WRN and MUS81 causes synthetic sickness in cells growing under oncogeneinduced replication stress, our results support the possibility of targeting cancer cells with an impaired replication fork recovery pathway by a specific inactivation of the other parallel pathway.
INTRODUCTION
Genome instability and DNA damage are characteristic features of cancer cells, and enhanced chromosomal instability often correlates with poor prognosis in human patients with cancer. 1, 2 Although the molecular causes of genomic instability in cancer cells are yet to be identified, in recent years, several studies have emphasized that the establishment of a sustained replication stress may be triggered by activation or over-expression of oncogenes, 3 and correlates with reduced nucleotide levels. 4 To deal with perturbed replication forks and ensure faithful duplication of the genome, mammalian cells have developed multiple pathways. Some of them control the stability of the stalled forks and process intermediates, which may form at stalled forks, such as reversed forks, to counteract endonucleolytic breakage and unwanted recombination events. 5, 6 Other mechanisms involve bypass of lesions causing the arrest by either specialized DNA polymerases, template-switching mediated by recombination, or recombination from a one-ended double strand break (DSB) generated at stalled forks after their collapse. 7, 8 All these different systems are finely regulated, and are thought to work in concert with the major pathway supervising genome stability in S-phase, that is the ataxia telangiectasia and Rad3 related (ATR)-dependent replication checkpoint. 9 --11 Despite the potential therapeutic relevance of this information, which of the different mechanisms, dealing with perturbed replication forks, is essential in the response to oncogene-induced replication stress is unknown. Indeed, as replication stress is expected to be a common feature of many rapidly proliferating tumors, the pathway selected by cancer cells to counteract replication stress and proliferate, could be targeted to induce their cell death. The recent observation that replication defects and genome instability triggered by oncogene activation would depend on reduction of nucleotide levels, 4 mimicking what could occur after hydroxyurea treatment and inhibition of the ribonucleotide reductase, contributes to reinforce the importance of pathways dealing with stalled replication forks in the response to oncogene activation. In humans, chromosome fragility syndromes are often associated with cancer predisposition, and are caused by loss or mutation of caretaker genes encoding for proteins involved in the response to perturbed replication forks. 12, 13 As such, cells from these genetic diseases are useful models to investigate how replication stress is handled, and to uncover alternative mechanisms of replication fork recovery. One of these genetic diseases is the Werner syndrome, which is caused by mutations in the WRN RecQ helicase. 13, 14 WRN has been implicated in different pathways managing perturbed replication, and loss of the protein results in increased DSBs during S-phase, 15 a feature that is also associated with cells experiencing oncogeneinduced replication stress. 3 We recently demonstrated that, in the absence of WRN, a different parallel pathway, which requires the MUS81 endonuclease, takes over to introduce DSBs and support recombination at stalled forks. 16 Here, we investigated whether oncogene-induced replication stress triggers the WRN-or the MUS81-dependent mechanism of replication recovery, to establish which of them is primarily involved in ensuring cell viability upon oncogene over-expression. Furthermore, we assessed whether loss of the WRN-dependent pathway of replication fork recovery determines the stimulation of the MUS81-dependent pathway, and its dependency for survival, also upon this particular type of replication perturbation. Our results indicate that, in response to oncogene-induced replication stress, the primary pathway responsible for both failsafe replication fork recovery and viability depends on WRN. Our experiments also demonstrate that DSBs formed in replicating cells after oncogene over-expression depends on MUS81, and that this pathway collaborates with WRN for viability. Finally, we show that oncogene-induced replication stress results in breakage at chromosome fragile sites, and that this form of chromosome instability is counteracted by WRN.
These results provide first insights into the mechanisms dealing with oncogene-induced replication stress, and identify factors that are essential for both genome stability and viability of oncogeneover-expressing cells.
RESULTS

Downregulation of WRN impairs cellular viability following oncogene-induced replication stress
Over-expression of some oncogenes, such as those deregulating the retinoblastoma pathway, has been demonstrated to induce a sustained perturbed replication or replication stress condition. 17 --19 As RecQ helicases have been shown to function in different pathways activated by replication stress, we analyzed whether the three human RecQ helicases, involved in the response to perturbed replication forks by either recombinogenic or nonrecombinogenic mechanisms, could affect cellular viability upon oncogene over-expression. As experimental model system, we chose to over-express two proto-oncogenes, Cyclin E (CycE) or E2F1, in wild-type hTERT-immortalized human primary fibroblasts, to mimic the deregulated expression that is observed in several human tumors, which is responsible for oncogene-induced replication stress. 19 --21 To confirm that CycE or E2F1 overexpression induced replication stress in our model system, we infected cells with increasing multiplicities of infection (MOI) of the recombinant virus Ad-CycE or Ad-E2F1, or the JpCA13 control virus. The level of CycE or E2F1 protein increased in a MOIdependent manner (Figures 1a and b) , and oncogene overexpression resulted in a dose-dependent accumulation of DNA damage, a readout of ongoing replication stress, as evaluated by immunofluorescence using the DSB marker g-H2AX, or by neutral comet assay (Supplementary Figures 1A and B) .
To explore the role of RecQ helicases in response to oncogeneinduced replication stress, we analyzed cellular viability upon 40 MOI CycE over-expression, in cells in which the function of BLM, RECQ5 or WRN had been depleted by RNAi. Even though all the short interfering RNAs (siRNAs) used efficiently downregulated the target proteins (Figure 1c ), only depletion of WRN determined an enhancement of cell death upon oncogene-induced replication stress (Figure 1d) . Similarly to what observed after CycE overexpression, loss of WRN also induced cell death in cells infected with the adenovirus expressing the E2F1 proto-oncogene (Figure 1d) .
Consistently with the requirement of WRN for viability under oncogene-induced replication stress, the percentage of WRN nuclear foci increased after infection with the Ad-CycE virus in a MOI-dependent manner ( Supplementary Figures 2A) but in a cellline-independent manner (Supplementary Figure 3B and C) . In U2OS cells, CycE over-expression determined the accumulation of WRN nuclear foci at sites of stalled or collapsed forks, as shown by co-localization of WRN with RPA32 or g-H2AX foci, two markers of stalled or collapsed forks, respectively (Supplementary Figures 2B  and C) .
These results suggest that the WRN helicase has a role in preventing cell death caused by oncogene-induced replication stress, probably protecting stalled and collapsed replication forks.
Oncogene-induced replication stress determines accumulation of MUS81-dependent DSBs that are prevented by WRN It has been shown that some oncogenes, including CycE, when activated determine formation of DSBs in replicating cells. 17 --19 We previously demonstrated that WRN prevents accumulation of MUS81-dependent DSBs under conditions of perturbed replication. 16 To explore the possibility that DSBs formed under oncogene-induced replication arrest derive from the action of the MUS81 endonuclease, and that WRN protects from these DSBs, we performed neutral comet assays in CycE overexpressing cells depleted of MUS81, WRN, or both by RNAi (Figures 2a and b) . As shown in Figure 2b , oncogene-induced replication stress determined formation of DSBs. DNA breakage occurred in replicating cells, as confirmed by BrdU-Comet assay (Figure 2c ). Interestingly, MUS81 knockdown suppressed DSBs induced by oncogene activation in wild-type cells (Figure 2b) . The observed effect of MUS81 depletion on the DSBs accumulation was unrelated to defects in the S-phase entry or progression because MUS81 knockdown did not induce any evident alteration in cell cycle progression at post-infection times corresponding to DSB suppression (Supplementary Figures 4A  and B) . Consistently, accumulation of MUS81-dependent DSBs in cells experiencing oncogene-induced replication stress was clearly observed also by immunofluorescence analysis of g-H2AX foci (Figure 2d ). Furthermore, neutral comet analysis and g-H2AX immunofluorescence independently showed that depletion of WRN determined an excess of MUS81-sensitive DSBs in cells over-expressing CycE (Figures 2b and d) . As showed in wild-type cells, also in WRN-depleted cells, the MUS81 effect on DSBs formation was not simply attributable to the only limited reduction of S-phase cells observed in the double WRN/MUS81 knockdown cells under asynchronous cell growth condition (Supplementary Figure 4C) .
We then performed chromatin fractionation experiments to evaluate the presence of hyper-activated MUS81 in WRN-deficient cells experiencing oncogene-induced replication stress (Figure 2e ). In WRN-proficient cells (siCtrl), the fraction of MUS81 associated with chromatin upon Ad-CycE infection barely increased, suggesting that the amount of MUS81 normally present in chromatin is sufficient to deal with replication forks perturbed by CycE overexpression. In contrast, in the absence of WRN (siWRN), the fraction of chromatin-associated MUS81 doubled, consistently with an increased requirement of the protein at perturbed forks that cannot be safeguarded by WRN.
To test whether WRN was required to allow faithful replication fork progression under oncogene-induced replication stress, we performed single-cell analysis of DNA replication by a sequential dual-labeling protocol in the presence or absence of oncogeneinduced replication stress (Supplementary Figure 5A) . As we did not detect a significant reduction of S-phase cells in asynchronously growing cells (Supplementary Figure 4C) , we used wildtype fibroblasts transfected with control siRNA (siCtrl) or siRNAs directed against WRN (siWRN) and enriched in S-phase by release after serum starvation before infection with Ad-CycE. Analysis of the ability of active replication factories to incorporate the second label allows to evaluate the occurrence of fork collapse and any other replication defects associated with replication under conditions of oncogene activation. We found that wild-type cells retained the ability to normally incorporate the second label in the large majority of active replication factories, even under conditions of oncogene-induced replication stress (Supplementary Figure 5B) . In contrast, WRN-deficient cells showed a decreased ability of the active replication factories to incorporate the second label in Ad-CycE-treated cells as well as about a 50% reduction in the number of cells incorporating the first label (Supplementary Figures 5B and C), suggesting that WRN is required for efficient replication under oncogene activation. Consistently with dual-labeling experiments, WRN-deficient cells showed a delayed progression through the S-phase following CycE over-expression compared with WRN-proficient cells (Supplementary Figure 5D ).
Altogether, these findings indicate that the oncogene-induced replication stress response requires both MUS81 and WRN functions, and that WRN is principally involved in counteracting formation of DSBs at stressed replication forks allowing their correct recovery.
WRN and MUS81 act independently to ensure viability under oncogene-induced replication stress Having demonstrated that WRN is essential to prevent MUS81-dependent DSBs formation, and to ensure correct replication upon oncogene activation, we next asked whether WRN and MUS81 might represent two independent mechanisms allowing survival under oncogene-induced replication stress. To this end, we performed viability assays in cells transfected with control siRNA or siRNAs directed against MUS81 (siMUS81), WRN (siWRN) or both (siMUS81/WRN; Figure 3a ), and infected with the Ad-Ctrl or Ad-CycE virus. CycE over-expression did not result in significant cell death 48 h after infection in siCtrl-transfected cells and only slightly increased the number of dead cells in MUS81-depleted cells (Figure 3b) . In contrast, a large percentage of cell death (50%) was observed in WRN-depleted cells experiencing oncogeneinduced replication stress, and this fraction was further increased Oncogene-induced replication stress and WRN I Murfuni et al by the concomitant downregulation of WRN and MUS81 (Figure 3b) . Interestingly, the effect on the viability was at least additive and the percentage of dead cells in the double WRN/ MUS81 knockdown approximated the number of S-phase cells in the population (data not shown).
These results indicate that WRN and MUS81 act in two independent pathways, even though the function of WRN is the most important for cell viability.
The checkpoint-dependent WRN phosphorylation is required for DSB prevention and cell viability under oncogene-induced replication stress In response to stalled or collapsed replication forks, WRN undergoes phosphorylation at S/TQ sites by ATR and ataxia telangiectasia mutated (ATM). 22, 23 Thus, we asked whether oncogene-induced replication stress was able to induce an ATR/ ATM-dependent WRN phosphorylation. To this aim, we infected U2OS cells with the Ad-CycE virus and performed western blotting using an anti-pS/TQ antibody on the immunoprecipitated WRN protein. As shown in Figure 4a , CycE over-expression determined a striking increase of the WRN reactivity toward the anti-pS/TQ antibody, which was partially prevented by treatment with the ATM inhibitor (KU55933) and completely abrogated by treatment with the ATR/ATM inhibitor caffeine (Figure 4a ), suggesting that, even though both checkpoint kinases may phosphorylate WRN, the role of ATR predominates.
We next determined whether the ATR/ATM unphosphorylable WRN-mutant (WSWRN In response to oncogene-induced replication stress, the ATR-dependent phosphorylation of WRN predominates over that ATM-dependent, and ATR has been shown to be particularly important for cell survival after oncogene activation. 24, 25 Thus, we next analyzed whether WRN6A and ATR could act in a same prosurvival pathway by performing RNAi-mediated downregulation of ATR in wild-type and WSWRN 6A cells (Figure 4e ). Live/dead viability assay showed that expression of the WRN6A mutant or ATR knockdown determined a comparable increase in cell death after CycE over-expression (Figure 4f ). Most importantly, depletion of ATR in WRN6A-expressing cells did not result in any additive phenotype, suggesting that phosphorylation of WRN is important for the pro-survival function of ATR under oncogene-induced replication stress.
Collectively, our data demonstrate that oncogene-induced replication stress triggers phosphorylation of WRN by ATR and ATM. However, the phosphorylation by ATR predominates and is functionally related with both DSBs avoidance and cellular viability.
Oncogene-induced replication stress determines excessive breakage at common fragile sites in the absence of WRN It has been reported that, in precancerous cells, oncogene expression triggers instability at common fragile sites (CFS), which are the natural hotspots of replication arrest in human cells. 1 To test whether WRN might protect oncogene-expressing cells from chromosome instability at CFS, the sensitivity of WRN-proficient (siCtrl) or WRN-deficient (siWRN) cells to oncogene-induced replication stress was investigated. Human fibroblasts were exposed to Ad-CycE at different MOIs and, 72 h later, metaphase chromosomes were collected and scored for total gaps and breaks (Figure 5a ). MOI-dependent induction of chromosome gaps and breaks was observed in both cell lines, with WRN-deficient fibroblasts showing higher levels of chromosomal damage in comparison with their wild-type counterparts (Figure 5a ). To verify whether the increase in chromosomal gaps and breaks observed in WRN-deficient cells after infection with Ad-Ctrl or Ad-CycE virus, takes place at specific DNA regions, the induction of the most frequently expressed CFS, FRA3B, were examined by fluorescence in situ hybridization (FISH) (Figure 5b) . In WRN-deficient cells, fragile site induction increased in a MOI-dependent manner, and was about two times higher than in wild-type cells (Figure 5b) .
Next, we determined whether chromosomal breaks formed after oncogene-induced replication stress would correlate with the MUS81-dependent DSBs formed during replication. Analyses of chromosome gaps and breaks in wild-type and WRN-deficient fibroblasts infected with Ad-Ctrl or Ad-CycE showed that depletion of MUS81 prevented accumulation of chromosome gaps and breaks in WRN-deficient cells as well as in WRN-proficient cells (Figure 5c ).
These results indicate that, in cells grown under conditions of oncogene-induced replication stress, the stability of CFS is affected by loss of WRN and that induction of chromatid gaps and breaks may be related to MUS81 activation.
DISCUSSION
It has been recently demonstrated that oncogene activation or over-expression is sufficient to induce DNA damage in normal cells.
1 Accumulation of such damage would derive from oncogene-induced replication stress, which is considered the leading cause of genome instability in a wide variety of tumors. 1, 26 However, even though the origin of replication stress caused by oncogene activation might be correlated with a shortage in the nucleotide supply, 4 the pathways involved in its resolution are not well known.
In this study, we show that oncogene-induced replication stress results in a strong dependency on the WRN protein for replication fork progression, DNA damage avoidance, and maintenance of common fragile site stability. We also demonstrate that MUS81 is responsible for DSB creation under oncogene-induced replication stress triggered by CycE over-expression, and that WRN and MUS81 synergize to sustain proliferation in the presence of CycEinduced oncogenic stress.
Formation of DSBs in oncogene-expressing cells has been widely reported, 17, 27, 28 and also our data demonstrate an increase in the amount of DSBs during replication under oncogene overexpression. Interestingly, loss of WRN increases the amount of DSBs formed after CycE over-expression and greatly impairs progression of replication forks, when cells are challenged with oncogene-induced replication stress. These observations are consistent with the requirement of WRN to sustain replication in c-Myc over-expressing cells 27 and with the reported reduced fork progression in WRN-deficient cells after DNA damage, 16, 29 suggesting that this function of WRN can be generalized whenever cells experience perturbed DNA replication. A possibility supported also by the recent finding of Bester and colleagues that correlated replication stress induced by oncogenes to replication under reduced nucleotide levels, 4 a mechanism reminiscent of what occurs after replication fork stalling mediated by inhibition of the ribonucleotide reductase triggered by hydroxyurea treatment. The strongly reduced ability of WRN-deficient cells to incorporate the second label in dual-labeling experiments together with the increased amount of DSBs formed during replication, suggest that WRN acts limiting fork collapse. Previous studies reported that oncogene-induced replication stress triggers accumulation of both cytological signs of stalled or collapsed replication forks, namely RPA or g-H2AX foci. 17 --19 We observe that WRN is recruited at both RPA and g-H2AX foci; however, the colocalization with RPA largely predominates, supporting the possibility that the main role of WRN is at stalled forks and that its loss determines an increased replication fork collapse.
The ATR-dependent checkpoint is essential to deal with activated oncogenes, as demonstrated by the huge amount of DNA damage accumulated by checkpoint-deficient cells after oncogene expression. 25, 30 Moreover, ATR downregulation and oncogene expression have been found synthetic lethal. 24, 25 After CycE over-expression, we find that WRN is phosphorylated at S/TQ sites in a manner that depends on both ATM and ATR, but we also show that phosphorylation by ATR is more evident. The observation that the ATR-dependent phosphorylation of WRN at S/TQ sites prevails over that ATM-dependent, which instead correlates with RAD51 engagement at collapsed forks, 22, 31, 32 would support the possibility that oncogene-induced replication stress is primarily a matter of fork stalling rather than fork collapse. Interestingly, expression of an ATR/ATM unphosphorylable WRN mutant, WRN6A, neither reverts the accumulation of DSBs after CycE over-expression nor reduces cell death caused by loss of WRN. Furthermore, either ATR downregulation or expression of the WRN6A allele gives a similar level of cell death after CycE overexpression, suggesting that most of the protective effect of ATR after oncogene-activation is mediated through WRN phosphorylation and confirming that WRN is a component of the S-phase checkpoint.
Intriguingly, we observe that depletion of the BLM or the RECQ5 protein, two other RecQ-like helicases involved in the response to perturbed replication, 33, 34 does not largely affect viability of cells following oncogene-induced replication stress. Thus, it is tempting to speculate that WRN may be the most important RecQ helicase to avoid cell death following oncogene-induced replication stress, consistently with the reported non-redundant roles of the different RecQ helicases. 14, 35 Whereas WRN may have a role either in the RAD51-dependent recombination or in the recovery of perturbed forks by the removal of recombination substrates arising at stalled forks, 16, 36, 37 BLM and RECQ5 have been demonstrated to work, albeit at different levels, during RAD51-dependent recombination. 34, 38, 39 Thus, it is likely that replication stress established after oncogene activation is not primarily handled by recombination.
Interestingly, DSBs formed in cells experiencing oncogeneinduced replication stress do not derive from a passive mechanism, but are dependent on the MUS81 endonuclease. The MUS81 endonuclease has been implicated in ensuring replication resumption at collapsed forks, likely promoting cleavage of a recombination intermediate, and competing with WRN for processing these substrates. 40 --44 Thus, it is conceivable that MUS81 may process replication intermediates, such as four-way junctions or regressed forks that are left unprocessed in the absence of WRN. The presence of unprocessed intermediates could also explain the elevated cell death observed in the double WRN/MUS81 knockdown cells after Ad-CycE-induced replication stress. Similarly, HJ endonucleases have been found essential in the absence of the BLM RecQ helicase. 41, 45 Moreover, we find that MUS81 downregulation suppresses also chromatid breaks induced after CycE over-expression in both wild-type cells and WRN knockdown cells. This finding may suggest that chromosome damage generated by oncogene-induced replication stress derives from the unscheduled processing of perturbed forks by MUS81. However, primarily in WRN-deficient cells, MUS81 downregulation also determines an elevated cell death making possible that the observed suppression of MUS81 on chromatid breaks is related to depletion from the population of heavily damaged cells. In contrast, MUS81 depletion in wild-type cells infected with AdCycE is not so elevated and, in this case, the reduction of damaged cells in mitosis is more likely to be ascribed to suppression of MUS81-dependent DSBs. From this point of view, our data on MUS81 involvement to produce DSBs in the absence of WRN extend and provide a mechanistic rationale for the seminal observations of Robinson and colleagues, 27 contributing to explain the reported reduced S-phase progression in WRNdeficient cells after c-Myc over-expression. Moreover, overexpression of c-Myc upregulates CycE, suggesting that the results obtained by Robinson and colleagues and ours may have a common cause.
One of the characteristic features of cells experiencing oncogene-induced replication stress, and of precancerous lesions, is the presence of genome instability at CFS, in a genetic background that is otherwise stable.
1 Accordingly, it has been speculated that CFS are the DNA regions in which the genomic instability, characteristic of later stages of tumor development, initiates.
1 Loss-of-heterozygosity events that are initiated at CFS by expression of CycE can be rescued by exogenous nucleotide supply, 4 suggesting that oncogenes drive instability at CFSenhancing fork stalling rate. Strikingly, we observe that instability at CFS, generated by oncogene-induced replication stress, is greatly reduced by WRN. This implies that WRN is required to sustain replication fork progression following oncogene activation, and that oncogene-induced replication stress exacerbates the normal function of WRN as replication caretaker at CFS. 46 Although loss of some proteins involved in the replication checkpoint enhances instability at CFS, 47 none of them, with the notable exception of BRCA1, has been found mutated in human cancers. In contrast, WRN has been found epigenetically silenced in different human tumors, 48 and it is possible that its downregulation may lead to enhanced genome instability and poor prognosis.
Because several human tumors seem to have either WRN or MUS81 downregulated, 48 --50 our results may set a mechanistic basis for a potential target therapy of specific cancers with defective WRN or MUS81-dependent pathway. It is worth noting that an inhibitor of the WRN helicase activity has been identified, and seems to be able to recapitulate the WS-like sensitivity to some drugs. 51 Overall, our findings give insights into the origin of DSBs accumulating during the oncogene-induced replication stress, and elucidate the mechanisms underlying the cellular response to this kind of replication perturbation. They may also help clarifying the mechanism at the basis of the reported involvement of WRN in sustaining proliferation after oncogene activation. 27 Finally, our results provide an intriguing rationale for developing a therapeutic strategy to target precancerous lesions, and to improve the conventional chemotherapeutic approach in WRN-deficient or MUS81-deficient human tumors.
MATERIALS AND METHODS
Cell cultures
The GM01604 hTERT-immortalized normal human fibroblasts were obtained from Coriell Cell Repositories (Camden, NJ, USA). The hTERT fibroblasts were cultured in DMEM (Life Technologies, Carlsbad, CA, USA) with 15% FBS (Boehringer, Mannheim, Germany). Cells were incubated at 37 1C in a 5% CO 2 atmosphere.
Adenovirus infection
The Ad-E2F1, Ad-CycE and empty JpCA13 (Ad-Ctrl) recombinant adenoviruses were generated, as previously reported. 52 Viral stocks were obtained as described. 52 Cell cultures were infected with the indicated MOI of virus in medium containing reduced serum (0.2%) for 1 h at 37 1C. Ad-Ctrl was used at MOI of 160. After infection, cells were replaced with the appropriate complete medium and then harvested after 72 h.
RNA interference and transfection WRN, MUS81, BLM, RecQ5 and ATR expression was knocked down by transfection with SMARTpool siRNAs (Dharmacon, Lafayette, CO, USA) directed against proteins of interest at the final concentration of 10 nM. Transfection was performed using Interferin (Polyplus-transfection, Illkirch, France) according to the manufacturer's instructions. As a control, a siRNA duplex directed against GFP was used.
Western blot and chromatin fractionation
Western blot and chromatin fractionation were performed as described. 16 Blots were incubated with primary antibodies against: WRN (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), MUS81 (Abcam, Cambridge, UK), BLM (Novus BioLabs), Cyclin E (Pharmingen), E2F1 (Santa Cruz Biotechnologies), RecQ5 (a gift of Dr Pavel Janscak, University of Zurich, Switzerland), ATR (Calbiochem), PCNA (Santa Cruz Biotechnology), TopoII b (Santa Cruz Biotechnology), and pS/TQ (Cell Signaling Technology, Danvers, MA, USA). After incubations with horseradish peroxidase-linked secondary antibodies (Vector Laboratories, Burlingame, CA, USA), the blots were developed using the chemiluminescence detection kit ECL-Plus (Amersham, Piscataway, NJ, USA), according to the manufacturer's instructions.
Immunofluorescence
Immunofluorescence microscopy was performed on cells grown on coverslips as described. 16 For g-H2AX detection, the primary antibodies used was an anti-g-H2AX (Millipore, Billerica, MA, USA). Immunofluorescence detection of BrdU was carried out on cells pulse-labeled with 30 mM BrdU (Sigma-Aldrich, Dorset, UK) 30 min before harvesting. Images were acquired as greyscale files using Metaview software (MDS Analytical Technologies, Sunnyvale, CA, USA) and processed using Photoshop (Adobe Systems Software Ireland Limited, Dublin, Irlanda) to adjust contrast and brightness of the image. For each time point, at least 200 nuclei were examined, and foci were scored at a Â 60 magnification. Only nuclei showing more than five bright foci were counted as positive. Parallel samples incubated with either the appropriate normal serum or only with the secondary antibody confirmed that the observed fluorescence pattern was not attributable to artifacts.
Comet assay
The occurrence of DNA double-strand breaks was evaluated by neutral Comet assay as described. 53 Cell DNA was stained with ethidium bromide (Sigma) and examined at Â 40 magnification with an Olympus fluorescence microscope. Slides were analyzed by a computerized image analysis system (Comet IV, Perceptive Instruments Ltd., Haverhill, UK). To assess the amount of DNA damage, computer-generated tail moment values (tail length Â fraction of total DNA in the tail) were used. A minimum of 200 cells was analyzed for each experimental point. Apoptotic cells (smaller comet head and extremely larger comet tail) were excluded from the analysis to avoid artificial enhancement of the tail moment. In some cases, cells were pulse-labeled with 30 mM BrdU (Sigma) for 30 min before analysis. BrdU incorporation was visualized by indirect immunofluorescence. 54 Live/dead staining GM01604 cells were transfected with siRNAs directed against GFP (control), or against WRN, MUS81, WRN/MUS81 or ATR before infection with Ad-Ctrl or Ad-CycE and harvested 72 h thereafter. Viability was evaluated by the LIVE/DEAD assay (Sigma-Aldrich), according to the manufacturer's instructions. LIVE/DEAD assay is a short-term viability assay that allows direct evaluation of the number of live cells, stained in green with calcein AM, and that of dead cells, stained in red with propidium iodide. Cell number was counted in randomly chosen fields and expressed as percent of dead cells (number of red nuclear stained cells/total cell number). For each time point, at least 200 cells were counted.
Immunoprecipitation and western blotting
For immunoprecipitation cells were lysed, as described in Ammazzalorso et al., 22 in the presence of 10U of benzonase and 1 mg of total cell extract incubated ON at þ 4 1C with either goat anti-WRN (Santa Cruz biotechnologies) or normal goat IgG (Calbiochem, La Jolla, CA, USA) antibody coupled to M280 tosylactivated Dynabeads (Invitrogen, Carlsbad, CA, USA). For western blotting analysis, the following antibodies were used: goat anti-WRN (Santa Cruz Biotechnology) and rabbit anti-pST/Q (Cell Signaling). Incubation with antibodies was performed for 2 h at RT or ON at þ 4 1C, respectively. Proteins were visualized using ECL plus, according to the manufacturer's instructions (Amersham).
Fragile site induction and fluorescence in situ hybridization Fragile sites were analyzed in GM01604 cells transfected with siRNAs directed against GFP (control) or against WRN before infection with Ad-Ctrl Oncogene-induced replication stress and WRN I Murfuni et al or Ad-CycE at the indicated MOIs and harvested 72 h thereafter. Cell cultures were incubated with 0.2 mg/ml colcemid at 37 1C for 3 h before harvesting. Metaphase cells were collected and prepared, as previously reported. 46 For each condition of treatment, the number of breaks and gaps was observed on Giemsa-stained metaphases.
A mix of the bacterial artificial chromosomes 94D19, 149J4, and 48E21 mapping to FRA3B region (kindly provided by Dr Daniela Toniolo Dibit-HSR, Milano, Italy and Dr Mariano Rocchi University of Bari, Italy) was used as probe for FISH analyses. Probes were labelled with a digoxigenin-11-dUTP nick translation kit (Roche, Burgess Hill, UK) according to the manufacturer's instructions. FISH analyses were performed as described. 46 
